147 related articles for article (PubMed ID: 7499327)
1. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells.
Andress DL
J Biol Chem; 1995 Nov; 270(47):28289-96. PubMed ID: 7499327
[TBL] [Abstract][Full Text] [Related]
2. Comparison studies of IGFBP-5 binding to osteoblasts and osteoblast-derived extracellular matrix.
Andress DL
Prog Growth Factor Res; 1995; 6(2-4):337-44. PubMed ID: 8817677
[TBL] [Abstract][Full Text] [Related]
3. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin.
Arai T; Clarke J; Parker A; Busby W; Nam T; Clemmons DR
J Biol Chem; 1996 Mar; 271(11):6099-106. PubMed ID: 8626396
[TBL] [Abstract][Full Text] [Related]
4. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding.
Campbell PG; Andress DL
Am J Physiol; 1997 Nov; 273(5):E1005-13. PubMed ID: 9374688
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans.
Yang YW; Yanagishita M; Rechler MM
Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497
[TBL] [Abstract][Full Text] [Related]
7. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells.
Andress DL; Loop SM; Zapf J; Kiefer MC
Biochem Biophys Res Commun; 1993 Aug; 195(1):25-30. PubMed ID: 7689835
[TBL] [Abstract][Full Text] [Related]
8. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration.
Abrass CK; Berfield AK; Andress DL
Am J Physiol; 1997 Dec; 273(6):F899-906. PubMed ID: 9435678
[TBL] [Abstract][Full Text] [Related]
9. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J
Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367
[TBL] [Abstract][Full Text] [Related]
10. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.
Arai T; Busby W; Clemmons DR
Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor.
Andress DL
Am J Physiol; 1998 Apr; 274(4):E744-50. PubMed ID: 9575837
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth.
Nam TJ; Busby WH; Rees C; Clemmons DR
Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain.
Twigg SM; Kiefer MC; Zapf J; Baxter RC
J Biol Chem; 1998 Oct; 273(44):28791-8. PubMed ID: 9786878
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells.
Mohan S; Nakao Y; Honda Y; Landale E; Leser U; Dony C; Lang K; Baylink DJ
J Biol Chem; 1995 Sep; 270(35):20424-31. PubMed ID: 7544787
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers.
Koedam JA; Hoogerbrugge CM; Van Buul-Offers SC
Biochem Biophys Res Commun; 1997 Nov; 240(3):707-14. PubMed ID: 9398631
[TBL] [Abstract][Full Text] [Related]
17. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action.
Andress DL; Birnbaum RS
J Biol Chem; 1992 Nov; 267(31):22467-72. PubMed ID: 1385400
[TBL] [Abstract][Full Text] [Related]
18. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action.
Conover CA; Clarkson JT; Bale LK
Endocrinology; 1996 Jun; 137(6):2286-92. PubMed ID: 8641177
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells.
Slootweg MC; Ohlsson C; van Elk EJ; Netelenbos JC; Andress DL
Growth Regul; 1996 Dec; 6(4):238-46. PubMed ID: 8971553
[TBL] [Abstract][Full Text] [Related]
20. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
